LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-08-27
Case ID: NM_000314.8_c.30_32del_20260827_190740
Framework: ACMG/AMP 2015
Variant classification summary

NM_000314.8:c.30_32del

PTEN  · NP_000305.3:p.(Ser10del)  · NM_000314.8
GRCh37: chr10:89624253 TAGC>T  ·  GRCh38: chr10:87864496 TAGC>T
Gene: PTEN Transcript: NM_000314.8
Final call
VUS
PM6 moderate PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Ser10del)
gnomAD AF
ClinVar
Uncertain Significance
OncoKB
Unknown Oncogenic Effect
Interpretation summary
Generated evidence synthesis
1
PM2 (Supporting): absent from gnomAD v2.1, v4.1, and gnomAD-Canada v1.0, below the 0.001% population frequency threshold.
2
PM6 (Moderate): one ClinVar clinical-laboratory record reports presumed de novo occurrence with a PTEN-consistent phenotype; maternity and paternity are unconfirmed, and possible germline mosaicism is flagged for human review.
3
VUS: PM6 (Moderate) plus PM2 (Supporting) matches no established Pathogenic, Likely Pathogenic, Benign, or Likely Benign combination rule.
Final determination: Under the ClinGen PTEN Expert Panel Version 3.2 criteria-combination framework, PM6 Moderate plus PM2 Supporting matches no final-classification rule and therefore yields VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Not met Not met: p.(Ser10del) is an in-frame single-codon deletion with no premature stop codon, so no nonsense-mediated decay is predicted.
cspec vcep_pvs1_decisiontree_pten
PS1 N/A Not applicable: PS1 applies only to amino-acid substitutions, and this variant is an in-frame deletion (p.(Ser10del)).
cspec
PS2 Not assessed Not assessed: confirmed maternity and paternity were not documented, which the PTEN PS2 rule requires for de novo evidence.
cspec clinvar
PS3 Not assessed Not assessed: no variant-specific result for p.(Ser10del) exists in the Mighell 2018 assay (PS3 requires phosphatase activity <= -1.11).
cspec vcep_mmc2 PMID:29706350
PS4 Not assessed Not assessed: neither a case-control result (odds ratio >2, p<0.05) nor proband phenotype data reaching the specificity score of 1 was available.
cspec clinvar
PM1 Not met Not met: residue 10 lies outside the PTEN catalytic motifs (WPD loop 90-94, P-loop 123-130, TI-loop 166-168).
cspec PMID:29706350
PM2 Met Met (Supporting): absent from gnomAD v2.1, v4.1, and gnomAD-Canada v1.0, below the 0.001% population frequency threshold.
cspec gnomad_v2 gnomad_v4 gnomad_canada
PM3 N/A Not applicable: the PTEN Expert Panel designates PM3 not applicable because PTEN-associated disease is autosomal dominant.
cspec
PM4 Not met Not met: PM4 requires an in-frame indel affecting a catalytic motif; Ser10 is outside motifs 90-94, 123-130, and 166-168.
cspec
PM5 N/A Not applicable: PM5 is restricted to missense substitutions, and this variant is an in-frame deletion (p.(Ser10del)).
cspec pm5_candidates
PM6 Met Met (Moderate): one ClinVar clinical-laboratory record reports presumed de novo occurrence with a PTEN-consistent phenotype, though maternity and paternity are unconfirmed. Flagged for human review: the record is a secondary submission that mentions possible germline mosaicism.
cspec clinvar
PP1 Not assessed Not assessed: no family co-segregation data was available (supporting strength requires at least 3 informative meioses).
cspec
PP2 N/A Not applicable: PP2 is restricted to missense variants, and this variant is an in-frame deletion.
cspec
PP3 Not assessed Not assessed: SpliceAI predicts no splice impact (max delta 0.037), but the required concordant VarSeak prediction is unavailable.
cspec spliceai
PP4 N/A Not applicable: the PTEN Expert Panel folds phenotype specificity into PS4, so PP4 does not apply.
cspec
PP5 N/A Not applicable: the ClinVar expert-panel assertion for this variant is Uncertain Significance, not Pathogenic or Likely Pathogenic.
cspec clinvar
BA1 Not met Not met: the variant is absent from gnomAD, well below the 0.056% filtering allele frequency required for BA1.
cspec gnomad_v2 gnomad_v4 gnomad_canada
BS1 Not met Not met: the variant is absent from gnomAD, with no observed frequency in the BS1 range (0.00043%-0.056%).
cspec gnomad_v2 gnomad_v4 gnomad_canada
BS2 Not assessed Not assessed: no homozygous observation in a healthy individual was available to support BS2.
cspec gnomad_v2 gnomad_v4 gnomad_canada
BS3 Not assessed Not assessed: no functional assay result for p.(Ser10del) was available (BS3 would require phosphatase activity >0 in Mighell 2018).
cspec vcep_mmc2 PMID:29706350
BS4 Not assessed Not assessed: no affected relatives lacking the variant were documented, so lack of segregation could not be established.
cspec
BP1 N/A Not applicable: the PTEN Expert Panel designates BP1 not applicable to PTEN.
cspec
BP2 Not assessed Not assessed: no phase, cis, or trans observations were available to establish BP2.
cspec
BP3 N/A Not applicable: explicitly designated not applicable by the PTEN Expert Panel.
cspec
BP4 Not assessed Not assessed: SpliceAI predicts no splice impact (max delta 0.037), but the required concordant VarSeak result is unavailable.
cspec spliceai
BP5 Not assessed Not assessed: no evidence of two affected cases with a separate highly penetrant molecular diagnosis was available.
cspec clinvar
BP6 N/A Not applicable: the ClinVar expert-panel assertion for this variant is Uncertain Significance, not Benign or Likely Benign.
cspec clinvar
BP7 N/A Not applicable: BP7 applies only to synonymous or intronic variants, and this is an exonic in-frame deletion.
cspec
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.